Simon Says

著者: Business RadioX ®
  • サマリー

  • Al Simon of Sandler Training by Simon interviews local business owners and sales professionals about some of the sales challenges they face and things they can do to increase sales for their organizations.
    © 2025 Business Radio X
    続きを読む 一部表示

あらすじ・解説

Al Simon of Sandler Training by Simon interviews local business owners and sales professionals about some of the sales challenges they face and things they can do to increase sales for their organizations.
© 2025 Business Radio X
エピソード
  • SIMON SAYS, LET’S TALK BUSINESS: Chris Lindenau with Fusus
    2023/03/23
    Chris Lindenau/Fusus Fusus is the most widely used and trusted real-time crime center platform in U.S. Law Enforcement. The Fusus platform is an open ecosystem that integrates and enhances all public safety and investigations assets. It can integrate with any data source, pull in public and private video feeds, enable video sources with artificial intelligence, […] The post SIMON SAYS, LET’S TALK BUSINESS: Chris Lindenau with Fusus appeared first on Business RadioX ®.
    続きを読む 一部表示
    1分未満
  • SIMON SAYS, LET’S TALK BUSINESS: Tim Yoder with Duratec Roofing Solutions and J.C. Laurent with Penon Partners
    2023/02/16
    Tim Yoder/Duratec Roofing Solutions Duratec Roofing Solutions is a commercial roofing company specializing in the coatings and restoration industry along with single-plys. Located in Monticello, GA they service all of Georgia and surrounding states. Their goal is to provide service and quality for long lasting customer relationships. Jean-Christophe (J.C.) Laurent/Penon Partners Penon Partners is […] The post SIMON SAYS, LET’S TALK BUSINESS: Tim Yoder with Duratec Roofing Solutions and J.C. Laurent with Penon Partners appeared first on Business RadioX ®.
    続きを読む 一部表示
    1分未満
  • SIMON SAYS, LET’S TALK BUSINESS: David Dodd with GeoVax
    2023/01/19
    David Dodd/GeoVax GeoVax Labs is a clinical-stage biotechnology company developing novel therapies and vaccines for cancers and many of the world's most threatening infectious diseases. The company's lead program in oncology is a novel oncolytic solid tumor gene-directed therapy, Gedeptin®, presently in a multicenter Phase 1/2 clinical trial for advanced head and neck cancers. GeoVax's […] The post SIMON SAYS, LET’S TALK BUSINESS: David Dodd with GeoVax appeared first on Business RadioX ®.
    続きを読む 一部表示
    1分未満

Simon Saysに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。